AT1 Atomo Diagnostics Limited

—Mkt Cap: —P/E: —

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. The company offers blood test devices, such as Pascal, Curie, Galileo, Elion, and Florey under the AtomoRapid brand. It also off…

Key Statistics

Company
Market Cap—
Enterprise Value8.30M USD
Revenue (TTM)3.69M USD
Gross Profit1.23M USD
Net Income (TTM)-2.43M USD
Revenue/Share0.0060 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU0000080327
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA-2.94
EV/Revenue2.25
P/S2.88
P/B1.89
EPS (TTM)0.00
EPS (Forward)-1.10
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin33.92%
Oper. Margin-82.07%
EBITDA Margin-76.64%
Profit Margin-67.21%
ROE-45.59%
ROA-32.46%
Growth
Revenue Growth81.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.33M USD
CapEx (TTM)24.41K USD
FCF Margin-52.05%
FCF Yield—
Net Debt-2.31M USD
Net Debt/EBITDA0.82
Balance Sheet
Debt/Equity0.05
Current Ratio3.04
Quick Ratio2.37
Book Value/Sh0.0090 AUD
Cash/Share0.0040 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.902.43M
Float524.57M
Insiders41.67%
Institutions5.65%
Technical
SMA 500.0178 AUD
SMA 2000.0254 AUD
Beta1.28
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)749.88K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—